CGEM Cullinan Therapeutics, Inc. logo

CGEM Cullinan Therapeutics, Inc.

Healthcare
$13.84-1.00%ClosedMarket Cap: $850.6M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

156

13F Shares

63,186,817

Ownership %

107.1%

New Positions

29

Increased Positions

93

Closed Positions

20

Reduced Positions

42

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBCVirtus Biotech Clinical Trials ETF22,8750.93%
CANCTema Oncology ETF62,0160.50%
XBI1,307,4610.25%
LABUDirexion Daily S&P Biotech Bull 3X ETF65,3760.18%
IJE135,9950.16%
IWCiShares Micro-Cap ETF135,9950.16%
AVSCAvantis U.S. Small Cap Equity ETF122,9120.07%
IBBiShares Biotechnology ETF323,4290.06%
VTWV40,3790.06%
IWNiShares Russell 2000 Value ETF460,2250.05%
NAJ460,2250.05%
PRFZInvesco RAFI US 1500 Small-Mid ETF93,1840.05%
SMLFiShares U.S. Small-Cap Equity Factor ETF103,2870.04%
IWMiShares Russell 2000 ETF1,315,5830.03%
NJM1,315,5830.03%
NUSCNuveen ESG Small-Cap39,0030.03%
VTWO267,6160.03%
VSTCX47,1300.02%
DFASDimensional - US Small Cap ETF192,7550.02%
RSSLGlobal X - Russell 2000 ETF24,6290.02%